Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Anticoagulant options--why the FDA approved a higher but not a lower dose of dabigatran.

× No keyword cloud information.

52 in total

1. Antithrombotic pharmacotherapy in the elderly: general issues and clinical conundrums.

Authors: Davide Capodanno; Dominick J Angiolillo
Journal: Curr Treat Options Cardiovasc Med Date: 2012-02

2. Fifty years after thalidomide; what role for drug regulators?

Authors: Hans-Georg Eichler; Eric Abadie; Mary Baker; Guido Rasi
Journal: Br J Clin Pharmacol Date: 2012-11 Impact factor: 4.335

3. Perspective on dabigatran etexilate dosing: why not follow standard pharmacological principles?

Authors: Paul K L Chin; Jane W A Vella-Brincat; Murray L Barclay; Evan J Begg
Journal: Br J Clin Pharmacol Date: 2012-11 Impact factor: 4.335

4. Dabigatran for periprocedural anticoagulation following radiofrequency ablation for atrial fibrillation: a meta-analysis of observational studies.

Authors: Benjamin A Steinberg; Vic Hasselblad; Brett D Atwater; Tristram D Bahnson; Jeffrey B Washam; John H Alexander; James P Daubert; Jonathan P Piccini
Journal: J Interv Card Electrophysiol Date: 2013-07-24 Impact factor: 1.900

Review 5. New oral anticoagulants in non-valvular atrial fibrillation.

Authors: Pietro Francia; Carmen Adduci; Daria Santini; Beatrice Musumeci; Giuliano Tocci
Journal: High Blood Press Cardiovasc Prev Date: 2013-05-08

Review 6. Dabigatran: review of pharmacology and management of bleeding complications of this novel oral anticoagulant.

Authors: Michael Ganetsky; Kavita M Babu; Steven D Salhanick; Robert S Brown; Edward W Boyer
Journal: J Med Toxicol Date: 2011-12

7. Pradaxa, bleeding and tort litigation solicitation.

Authors: Greg Flaker
Journal: Mo Med Date: 2012 May-Jun

8. Good decision making requires good communication.

Authors: Baruch Fischhoff
Journal: Drug Saf Date: 2012-11-01 Impact factor: 5.606

Review 9. Clinical considerations of anticoagulation therapy for patients with atrial fibrillation.

Authors: Shu Zhang
Journal: J Zhejiang Univ Sci B Date: 2012-08 Impact factor: 3.066

Review 10. Real Data on Effectiveness, Tolerability and Safety of New Oral Anticoagulant Agents: Focus on Dabigatran.

Authors: Eugenio Stabile; Raffaele Izzo; Francesco Rozza; Maria Angela Losi; Enrico Coscioni; Bruno Trimarco
Journal: High Blood Press Cardiovasc Prev Date: 2016-05-20